References
- Moon H W, Chang Y H, Kim T Y, Oh B R, Min H C, Kim B K, et al. Incidence of submicroscopic deletions vary according to disease entities and chromosomal translocations in hematologic malignancies: investigation by fluorescence in situ hybridisation. Cancer Genet Cytogenet 2007; 175: 166–168
- Kolomietz E, Al-Maghrabi J, Brennan S, Karaskova J, Minkin S, Lipton J, et al. Primary chromosomal rearrangements of leukemia are frequently accompanied by extensive submicroscopic deletions and may lead to altered prognosis. Blood 2001; 97: 3581–3588
- Cohen N, Rozenfeld-Granot G, Hardan I, Brok-Simoni F, Amariglio N, Rechavi G, et al. Subgroup of patients with Philadelphia-positive chronic myelogenous leukemia characterized by a deletion of 9q proximal to ABL gene: expression profiling, resistance to interferon therapy, and poor prognosis. Cancer Genet Cytogenet 2001; 128: 114–119
- Attarbaschi A, Mann G, König M, Dworzak M N, Trebo M M, Mühlegger N, et al. Incidence and relevance of secondary chromosome abnormalities in childhood TEL/AML1+ acute lymphoblastic leukemia: an interphase FISH analysis. Leukemia 2004; 18: 1611–1616
- Subramaniyam S, Nadula S V, Nichols G, Weiner M, Satwani P, Alobeid B, et al. Do RARA/PML fusion gene deletions confer resistance to ATRA-based therapy in patients with acute promyelocytic leukemia?. Leukemia 2006; 20: 2193–2195
- Stavropoulou C, Georgakakos V N, Manola K N, Pagoni M, Garofalaki M, Panelias G E, et al. 5′ RARA submicroscopic deletion from new variant translocation involving chromosomes 15, 17, and 18, in a case of acute promyelocytic leukemia. Cancer Genet Cytogenet 2008; 182: 50–55